Claude AI robotics benchmark shows Opus 4.7 finishing physical robot programming in 9 minutes, against 181 minutes for ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...

Renewables accounted for 30.0% of total US electrical generation during the first third of 2026, according to new EIA data.

L3Harris Technologies expands Arkansas production with two new facilities for PAC-3 missile propulsion systems.

Aptiv provides sensor fusion from radar and vision using AI to enable Robust.AI's Carter robot to move safely around people.

Quanten Technologies Inc., a pioneer in advanced electric motor technology, recently debuted its latest breakthrough innovations at the annual Robotics Summit & Expo in Boston. Quanten officially ...

MotoGP and Yamaha Motor Co., Ltd. today announced a new long-term project that will see Yamaha become the exclusive ...

PARP inhibitors reshaped oncology when they first reached patients some 10 years ago, but they represent just one entry point into a much larger and more intricate biological network.

U.S. federal support helped TerraPower and Kairos Power start building full-sized demonstration advanced reactors in April, ...

The proposed fundraise, in one or more tranches, will be used to support research and development, expand marketing ...

Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of ...

GEN Ilac ve Saglik Urunleri A.S. Proof-of-concept SHEPHERD study will assess SUL-238’s effects on mitochondrial function in patients with Parkinson’s disease. ANKARA, TR / ACCESS Newswire / June 8, ...